Evoke Pharma
EVOK
#10300
Rank
ยฃ2.6 M
Marketcap
ยฃ1.74
Share price
-3.02%
Change (1 day)
-70.35%
Change (1 year)

Operating Margin for Evoke Pharma (EVOK)

Operating Margin as of April 2025 (TTM): -47.32%

According to Evoke Pharma 's latest financial reports and stock price the company's current Operating Margin is -47.32%. At the end of 2024 the company had an Operating Margin of -52.22%.

Operating Margin history for Evoke Pharma from 2021 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-52.22%-65.28%
2023-150.41%-54.12%
2022-327.83%-37.87%
2021-527.66%-99.08%
2020-57,144.53%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
18.91%-139.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.61%-92.37%๐Ÿ‡บ๐Ÿ‡ธ USA
30.07%-163.55%๐Ÿ‡บ๐Ÿ‡ธ USA
-10.86%-77.05%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.